Overview
Also known as:
FDA & Trial Timeline
4 eventsThe First Affiliated Hospital with Nanjing Medical University — PHASE2
The First Affiliated Hospital with Nanjing Medical University
Beleodaq: FDA approved
Treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Adcetris: FDA approved
The treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
4 availablePOLIVY
in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), …
in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL) and who have an International Prognostic Index score of 2 or greater
Folotyn
FOLOTYN is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
Lymphir
LYMPHIR is indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy
Beleodaq
Treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
3 resourcesTravel Grants
No travel grants are currently matched to Primary cutaneous peripheral T-cell lymphoma not otherwise specified.
Community
No community posts yet. Be the first to share your experience with Primary cutaneous peripheral T-cell lymphoma not otherwise specified.
Start the conversation →Latest news about Primary cutaneous peripheral T-cell lymphoma not otherwise specified
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary cutaneous peripheral T-cell lymphoma not otherwise specified
Are there clinical trials for Primary cutaneous peripheral T-cell lymphoma not otherwise specified?
Yes — 1 recruiting clinical trial is currently listed for Primary cutaneous peripheral T-cell lymphoma not otherwise specified on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Primary cutaneous peripheral T-cell lymphoma not otherwise specified?
7 specialists and care centers treating Primary cutaneous peripheral T-cell lymphoma not otherwise specified are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Primary cutaneous peripheral T-cell lymphoma not otherwise specified?
4 patient support programs are currently tracked on UniteRare for Primary cutaneous peripheral T-cell lymphoma not otherwise specified. See the treatments and support programs sections for copay assistance, eligibility, and contact details.